EDITORIAL SECTIONS

Amisha Raikar is a highly motivated individual with a strong educational background in the field of pharmaceutics. She completed her Bachelor of Pharmacy (B-Pharm) from Goa University in 2022, which laid the foundation for her journey into the pharmaceutical industry. Building upon her undergraduate degree, Amisha decided to pursue Master of Pharmacy (M-Pharm) in pharmaceutical science and formulation development. Recognising the importance of expanding her skill set beyond the technical aspects of pharmaceuticals, she embarked on a Postgraduate Diploma in International Business Management from the Indira Gandhi National Open University (IGNOU). Amisha's passion for learning and her desire to contribute to the field of pharmaceuticals has fueled her interest in pursuing a Ph.D. With her strong educational background, practical experience, and an eagerness to pursue further studies, Amisha Raikar is poised to make significant contributions to the field of pharmaceuticals through her future endeavours, such as a Ph.D. program.

Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry 

Rishabh Rajkumar Jadhav, who is developing antibacterial proteins to tackle antimicrobial resistance and received a SARTHI fellowship. Research Scholar. Currently working on plant bioengineering for therapeutic protein production. Working on Molecular biology techniques (Gene cloning, CRISPR-Cas), Plant tissue culture, and Microbiology.

Deepa Khare, an Associate Professor at Bennett University, holds a Ph.D. and postdoc in plant molecular biology from POSTECH, South Korea. She leads a project on plant-based biotherapeutics with her research scholar.

Lalit M Pandey is an Associate Professor at the Department of Biosciences and Bioengineering, IIT Guwahati. His main research interests include biointerfaces and biomaterials, biochemical engineering, and environmental biotechnology. He has published over hundred research articles in international journals and serves on the editorial board of six international journals. He is serving as Associate Editor in Frontiers in Bioengineering and Biotechnology. He has co-edited three books. He is a life member of the International Association of Engineers (IAENG), the National Academy of Sciences (NASI), the Indian Institute of Chemical Engineers (IIChE), the Biotech Research Society, India (BRSI), and Nano and Molecular Society (India) and serves as a reviewer for several peer-reviewed journals.

Dr Reuben Carr has over 25 years of experience in developing proprietary biocatalytic processes for fine chemical and pharmaceutical manufacturing. He specialises in using directed evolution to engineer natural enzymes to carry out novel chemical reactions, enabling the synthesis of challenging molecular targets for clients and customers.